Lacosamide
85 NDCs across 21 manufacturers|73 Generic,12 Brand
Lacosamide is used to treat partial epilepsies, tonic-clonic epilepsy and lennox gastaut syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 28, 2008, and the first generic was approved Mar 17, 2022. FDA's Orange Book lists 52 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $176 million on Lacosamide across 932,000 claims for 126,000 beneficiaries.
Lacosamide is available as 85 NDCs from 21 manufacturers (73 generic, 12 brand), with NADAC prices from $0.11 to $21.51 per EA — the most expensive product costs about 203× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
85
73G / 12B
Manufacturers
21
competing in market
Price Spread
$0.11 – $21.51
per EA, 74 of 85 NDCs
7d Activity
avg +2.3% WoW · of 85 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
UCB, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
21 manufacturers producing LACOSAMIDE(7 pricing outliers)
Frequently Asked Questions
What is Lacosamide used to treat?
Lacosamide is used to treat partial epilepsies, tonic-clonic epilepsy and lennox gastaut syndrome, per the National Library of Medicine's MED-RT classification.
When did Lacosamide become available as a generic?
FDA approved the first generic Lacosamide (ANDA) on Mar 17, 2022. The Orange Book currently lists 52 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Lacosamide?
In 2024, Medicare Part D spent $176 million on Lacosamide across 932,000 claims for 126,000 beneficiaries.
How many Lacosamide products are on the market?
The Lacosamide drug market contains 85 NDCs from 21 manufacturers — 73 generic and 12 brand products.
What is the price range for Lacosamide?
NADAC reference prices for Lacosamide range from $0.1061 to $21.5109 per EA — the most expensive product costs about 203× the cheapest. 11 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Lacosamide cheaper than brand?
The average generic NADAC for Lacosamide is $0.1938 per EA, versus $18.5187 for brand-labeled products — brand versions average about 96× the generic price.
Which manufacturers make Lacosamide?
21 manufacturers list Lacosamide in NADAC. Ranked by number of NDCs, the largest are UCB, Inc. (9), Breckenridge Pharmaceutical Inc. (8), Aurobindo Pharma Limited (5), NorthStar Rx LLC (5), Camber Pharmaceuticals Inc. (5).
How has the price of Lacosamide changed recently?
Over the past 7 days, 70 Lacosamide NDCs rose and 2 fell, with a market-wide average change of +2.3%.